US Stock MarketDetailed Quotes

CORT Corcept Therapeutics

Watchlist
  • 51.400
  • +0.250+0.49%
Close Dec 20 16:00 ET
  • 52.550
  • +1.150+2.24%
Post 20:01 ET
5.39BMarket Cap40.79P/E (TTM)

Corcept Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
39.54%73.83M
-2.61%41.18M
-8.48%23.76M
5.58%127.04M
-82.37%5.89M
57.24%52.91M
134.40%42.29M
-26.36%25.96M
-28.33%120.32M
-32.45%33.39M
Net income from continuing operations
50.47%47.21M
28.92%35.49M
74.83%27.76M
4.66%106.14M
88.87%31.36M
-9.33%31.38M
0.42%27.53M
-30.35%15.88M
-9.86%101.42M
-48.21%16.6M
Depreciation and amortization
72.66%499K
-78.98%198K
-79.16%179K
-31.46%2.36M
-77.78%272K
-61.57%289K
41.02%942K
7.11%859K
-0.86%3.45M
1.49%1.22M
Deferred tax
-71.69%-15.21M
-36.39%-13.96M
-6.48%-7.16M
13.01%-29.49M
17.80%-3.67M
0.18%-8.86M
3.69%-10.24M
32.30%-6.73M
-880.14%-33.91M
-294.30%-4.47M
Change In working capital
40.61%28.09M
-47.56%7.28M
-217.54%-7.41M
48.37%8.22M
-411.68%-31.94M
648.19%19.98M
228.69%13.87M
-35.09%6.31M
1,288.63%5.54M
478.60%10.25M
-Change in receivables
-183.65%-5.88M
191,925.00%7.68M
-326.33%-6.4M
42.26%-10.07M
58.47%-6.5M
-65.84%-2.07M
100.41%4K
-435.57%-1.5M
-1,121.58%-17.43M
-1,300.45%-15.64M
-Change in inventory
298.71%1.08M
-282.32%-1.68M
76.16%983K
5.50%1.27M
163.20%329K
-229.83%-544K
12.71%922K
442.33%558K
-65.19%1.2M
-84.16%125K
-Change in prepaid assets
200.64%6.59M
-814.75%-1.74M
395.47%3.61M
-76.96%-11.6M
-203.75%-6.02M
23.54%-6.55M
106.45%244K
8,200.00%729K
-63.68%-6.56M
437.95%5.81M
-Change in payables and accrued expense
-10.38%26.19M
-72.90%3.6M
-180.29%-5.69M
-3.41%31.39M
-180.85%-18.19M
362.81%29.22M
311.60%13.28M
-28.89%7.09M
1,892.83%32.5M
578.88%22.5M
-Change in other current assets
---34K
---551K
--153K
24.91%-1.48M
---1.48M
--0
--0
--0
-203.03%-1.98M
----
-Change in other current liabilities
297.22%142K
94.96%-29K
86.80%-75K
41.38%-1.29M
86.88%-74K
87.07%-72K
-4.17%-575K
-7.98%-568K
-8.59%-2.2M
-8.46%-564K
Cash from discontinued investing activities
Operating cash flow
39.54%73.83M
-2.61%41.18M
-8.48%23.76M
5.58%127.04M
-82.37%5.89M
57.24%52.91M
134.40%42.29M
-26.36%25.96M
-28.33%120.32M
-32.45%33.39M
Investing cash flow
Cash flow from continuing investing activities
59.81%-44.04M
-149.80%-60.19M
-104.34%-9.01M
179.51%90.91M
199.17%17.1M
-2,187.47%-109.57M
42.35%-24.1M
510.87%207.48M
-183.99%-114.33M
-112.27%-17.24M
Net PPE purchase and sale
-4,318.92%-1.64M
----
----
66.34%-139K
--0
89.46%-37K
----
----
11.94%-413K
52.31%-31K
Net investment purchase and sale
61.29%-42.4M
-149.13%-59.78M
-104.34%-9.01M
179.92%91.05M
199.35%17.1M
-2,367.52%-109.53M
42.57%-24M
510.97%207.48M
-183.40%-113.91M
-112.25%-17.21M
Cash from discontinued investing activities
Investing cash flow
59.81%-44.04M
-149.80%-60.19M
-104.34%-9.01M
179.51%90.91M
199.17%17.1M
-2,187.47%-109.57M
42.35%-24.1M
510.87%207.48M
-183.99%-114.33M
-112.27%-17.24M
Financing cash flow
Cash flow from continuing financing activities
-438.61%-21.09M
98.52%-2.15M
-400.00%-543K
-760.47%-148.72M
1,355.74%766K
71.95%-3.92M
-5,188.61%-145.75M
135.77%181K
94.29%-17.28M
99.97%-61K
Net common stock issuance
--0
----
----
---145.43M
--0
--0
----
----
--0
--0
Proceeds from stock option exercised by employees
-925.98%-9.44M
-116.09%-241K
-13.91%1.21M
32.64%5.81M
124.33%1.76M
-83.33%1.14M
132.26%1.5M
1.95%1.41M
-73.01%4.38M
-74.24%785K
Net other financing activities
-130.30%-11.65M
-4.66%-1.91M
-43.00%-1.76M
57.97%-9.11M
-17.61%-995K
---5.06M
---1.82M
34.96%-1.23M
5.12%-21.67M
66.38%-846K
Cash from discontinued financing activities
Financing cash flow
-438.61%-21.09M
98.52%-2.15M
-400.00%-543K
-760.47%-148.72M
1,355.74%766K
71.95%-3.92M
-5,188.61%-145.75M
135.77%181K
94.29%-17.28M
99.97%-61K
Net cash flow
Beginning cash position
-25.40%128.59M
-50.07%149.75M
104.36%135.55M
-14.54%66.33M
122.52%111.8M
387.68%172.38M
384.86%299.94M
-14.54%66.33M
1.87%77.62M
-46.94%50.24M
Current changes in cash
114.36%8.7M
83.41%-21.16M
-93.92%14.2M
713.24%69.22M
47.65%23.75M
-506.64%-60.58M
-381.09%-127.57M
1,582.79%233.61M
-891.03%-11.29M
194.23%16.09M
End cash Position
22.80%137.29M
-25.40%128.59M
-50.07%149.75M
104.36%135.55M
104.36%135.55M
122.52%111.8M
387.68%172.38M
384.86%299.94M
-14.54%66.33M
-14.54%66.33M
Free cash flow
36.54%72.19M
-3.36%40.77M
-8.48%23.76M
5.83%126.9M
-82.35%5.89M
58.79%52.87M
134.08%42.18M
-26.33%25.96M
-28.38%119.91M
-32.42%33.36M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 39.54%73.83M-2.61%41.18M-8.48%23.76M5.58%127.04M-82.37%5.89M57.24%52.91M134.40%42.29M-26.36%25.96M-28.33%120.32M-32.45%33.39M
Net income from continuing operations 50.47%47.21M28.92%35.49M74.83%27.76M4.66%106.14M88.87%31.36M-9.33%31.38M0.42%27.53M-30.35%15.88M-9.86%101.42M-48.21%16.6M
Depreciation and amortization 72.66%499K-78.98%198K-79.16%179K-31.46%2.36M-77.78%272K-61.57%289K41.02%942K7.11%859K-0.86%3.45M1.49%1.22M
Deferred tax -71.69%-15.21M-36.39%-13.96M-6.48%-7.16M13.01%-29.49M17.80%-3.67M0.18%-8.86M3.69%-10.24M32.30%-6.73M-880.14%-33.91M-294.30%-4.47M
Change In working capital 40.61%28.09M-47.56%7.28M-217.54%-7.41M48.37%8.22M-411.68%-31.94M648.19%19.98M228.69%13.87M-35.09%6.31M1,288.63%5.54M478.60%10.25M
-Change in receivables -183.65%-5.88M191,925.00%7.68M-326.33%-6.4M42.26%-10.07M58.47%-6.5M-65.84%-2.07M100.41%4K-435.57%-1.5M-1,121.58%-17.43M-1,300.45%-15.64M
-Change in inventory 298.71%1.08M-282.32%-1.68M76.16%983K5.50%1.27M163.20%329K-229.83%-544K12.71%922K442.33%558K-65.19%1.2M-84.16%125K
-Change in prepaid assets 200.64%6.59M-814.75%-1.74M395.47%3.61M-76.96%-11.6M-203.75%-6.02M23.54%-6.55M106.45%244K8,200.00%729K-63.68%-6.56M437.95%5.81M
-Change in payables and accrued expense -10.38%26.19M-72.90%3.6M-180.29%-5.69M-3.41%31.39M-180.85%-18.19M362.81%29.22M311.60%13.28M-28.89%7.09M1,892.83%32.5M578.88%22.5M
-Change in other current assets ---34K---551K--153K24.91%-1.48M---1.48M--0--0--0-203.03%-1.98M----
-Change in other current liabilities 297.22%142K94.96%-29K86.80%-75K41.38%-1.29M86.88%-74K87.07%-72K-4.17%-575K-7.98%-568K-8.59%-2.2M-8.46%-564K
Cash from discontinued investing activities
Operating cash flow 39.54%73.83M-2.61%41.18M-8.48%23.76M5.58%127.04M-82.37%5.89M57.24%52.91M134.40%42.29M-26.36%25.96M-28.33%120.32M-32.45%33.39M
Investing cash flow
Cash flow from continuing investing activities 59.81%-44.04M-149.80%-60.19M-104.34%-9.01M179.51%90.91M199.17%17.1M-2,187.47%-109.57M42.35%-24.1M510.87%207.48M-183.99%-114.33M-112.27%-17.24M
Net PPE purchase and sale -4,318.92%-1.64M--------66.34%-139K--089.46%-37K--------11.94%-413K52.31%-31K
Net investment purchase and sale 61.29%-42.4M-149.13%-59.78M-104.34%-9.01M179.92%91.05M199.35%17.1M-2,367.52%-109.53M42.57%-24M510.97%207.48M-183.40%-113.91M-112.25%-17.21M
Cash from discontinued investing activities
Investing cash flow 59.81%-44.04M-149.80%-60.19M-104.34%-9.01M179.51%90.91M199.17%17.1M-2,187.47%-109.57M42.35%-24.1M510.87%207.48M-183.99%-114.33M-112.27%-17.24M
Financing cash flow
Cash flow from continuing financing activities -438.61%-21.09M98.52%-2.15M-400.00%-543K-760.47%-148.72M1,355.74%766K71.95%-3.92M-5,188.61%-145.75M135.77%181K94.29%-17.28M99.97%-61K
Net common stock issuance --0-----------145.43M--0--0----------0--0
Proceeds from stock option exercised by employees -925.98%-9.44M-116.09%-241K-13.91%1.21M32.64%5.81M124.33%1.76M-83.33%1.14M132.26%1.5M1.95%1.41M-73.01%4.38M-74.24%785K
Net other financing activities -130.30%-11.65M-4.66%-1.91M-43.00%-1.76M57.97%-9.11M-17.61%-995K---5.06M---1.82M34.96%-1.23M5.12%-21.67M66.38%-846K
Cash from discontinued financing activities
Financing cash flow -438.61%-21.09M98.52%-2.15M-400.00%-543K-760.47%-148.72M1,355.74%766K71.95%-3.92M-5,188.61%-145.75M135.77%181K94.29%-17.28M99.97%-61K
Net cash flow
Beginning cash position -25.40%128.59M-50.07%149.75M104.36%135.55M-14.54%66.33M122.52%111.8M387.68%172.38M384.86%299.94M-14.54%66.33M1.87%77.62M-46.94%50.24M
Current changes in cash 114.36%8.7M83.41%-21.16M-93.92%14.2M713.24%69.22M47.65%23.75M-506.64%-60.58M-381.09%-127.57M1,582.79%233.61M-891.03%-11.29M194.23%16.09M
End cash Position 22.80%137.29M-25.40%128.59M-50.07%149.75M104.36%135.55M104.36%135.55M122.52%111.8M387.68%172.38M384.86%299.94M-14.54%66.33M-14.54%66.33M
Free cash flow 36.54%72.19M-3.36%40.77M-8.48%23.76M5.83%126.9M-82.35%5.89M58.79%52.87M134.08%42.18M-26.33%25.96M-28.38%119.91M-32.42%33.36M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Micron Technology
MU
+3.48%
NVIDIA
NVDA
+3.08%
Intel
INTC
+2.41%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%

Unlock the Full List